S. Murphy

Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.

J. Herman, S. Baylin, M. Brock, 2011, Cancer discovery.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.

D. L. Wilburn, L. Cope, L. Cope, 2008, Cancer research.

Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer

C. Rudin, L. Marchionni, S. Murphy, 2013, Molecular Cancer.

ERK Phosphorylation Is Predictive of Resistance to IGF-1R Inhibition in Small Cell Lung Cancer

C. Rudin, L. Marchionni, S. Murphy, 2013, Molecular Cancer Therapeutics.

Inhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene-Driven Non–Small Cell Lung Cancer

C. Rudin, P. Tran, T. Burns, 2013, Molecular Cancer Research.

Cell Cycle and Senescence Inhibition of TWIST 1 Leads to Activation of Oncogene-Induced Senescence in Oncogene-Driven Non – Small Cell Lung Cancer

C. Rudin, P. Tran, T. Burns, 2013 .

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

C. Rudin, R. Govindan, A. Argiris, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ERK Phosphorylation Is Predictive of Resistance to IGF-1R Inhibition in Small Cell Lung Cancer

C. Rudin, L. Marchionni, S. Murphy, 2013, Molecular Cancer Therapeutics.

Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.

J. Herman, S. Baylin, M. Brock, 2011, Cancer discovery.